Celgene (CELG) Tops Q1 EPS by 12c, Guides FY EPS In-Line

Celgene (NASDAQ: CELG) reported Q1 EPS of $2.55, $0.12 better than the analyst estimate of $2.43. Revenue for the quarter came in at $4.03 billion versus the consensus estimate of $4.01 billion.

GUIDANCE:

Celgene sees FY2019 EPS of $10.60-$10.80, versus the consensus of $10.70. Celgene sees FY2019 revenue of $17-17.2 million, versus the consensus of $17.11 million.

For earnings history and earnings-related data on Celgene (CELG) click here.

You May Also Be Interested In

• Klarna shares tumble on weak full-year revenue guidance
• Terra Innovatum Global N.V. (NKLR) Misses Q2 EPS by 12c
• Hesai Group (HSAI) Tops Q1 EPS by 8c